MedTrace Logo

A Trial of Enteral Colostrum on Intestinal Permeability in Critically Ill Patients

NCT03186716 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2018-04-17

No results posted yet for this study

Summary

The effects of colostrum on intestinal permeability in critical ill patients has not been investigated. In current trial, intensive care unit patients with enteral feeding will receive either enteral colostrum or maltodextrin as placebo.

Conditions

  • Critical Illness

Interventions

DIETARY_SUPPLEMENT

Colostrum

Enteral colostrum 20g/day powdered colostrum to be mixed in with water and given via nasogastric tube q4 hrs.

DIETARY_SUPPLEMENT

Maltodextrin

Control patients will be received enteral formula and maltodextrin mixed in with water and given via nasogastric tube as boluses q 4hrs.

Sponsors & Collaborators

  • National Nutrition and Food Technology Institute

    lead OTHER

Principal Investigators

  • Ghazaleh Eslamian, MS,PhDcandid · National Nutrition and Food Technology Research Institute Shahid Beheshti University of Medical Sciences, Tehran, Iran

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-11
Primary Completion
2018-01-25
Completion
2018-03-11

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03186716 on ClinicalTrials.gov